NEWS AFFECTING THE NOOB
Please scroll down for latest news
SMILEDIRECTCLUB EXPANDS ORAL CARE LINE WITH LAUNCH OF TWO NEW WATER FLOSSERS
26 October 2021
NASHVILLE, Tenn., Oct. 25, 2021 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. the innovative, next generation oral care company with the first medtech platform for teeth straightening, today announced the addition of two new water flossers to help customers maintain a healthy smile wherever they go. The innovative new Large Tank and Compact Water Flossers are more effective than string floss and complement SmileDirectClub’s award-winning existing product offerings, including the bestselling whitening systems and various other premium oral care products which are available at Walmart, Amazon and the company’s own website.
Source: SmileDirectClub, LLC
Will be super keen to sell put if price stay around here or goes lower by next month. All put entries already fully loaded.
FACEBOOK EARNINGS TAKEAWAY
26 October 2021
-
Monthly active users came in at 2.9 billion, matching analysts' forecasts.
-
Facebook uses monthly active users to measure the size of its global active user base, which it monetizes through the sale of ad space on its social media platform.
-
The company will begin reporting results for its new Facebook Reality Labs segment in the fourth quarter.
-
Facebook authorized an additional $50 billion in stock buybacks.
By
MATTHEW JOHNSTON
INVESTOPEDIA
Not vested in FB but it's a good guide for Google's earning tomorrow.
WILL OCUGEN BE APPROVED BY WHO?
26 October 2021
Ocugen is the American biotech company partnered with Indian firm Bharat Biotech. Bharat has been very successful in gaining approvals in India for its COVAXIN vaccine. However, regulators in the United States and other countries have been slower to adopt vaccines made outside of Europe and the U.S. This is tricky for Ocugen, which is looking to leverage its commercialization and development rights in U.S. and Canada.
Much of this roadblock has to do with the World Health Organization (WHO) approval process for vaccines.
Today, various reports of a WHO meeting to discuss COVAXIN have sent shares of Ocugen higher. Reportedly, the WHO’s technical advisory group is meeting on Tuesday, Oct. 26 to discuss the Bharat Biotech Covid-19 shot.
According to a tweet from WHO chief scientist Soumya Swaminathan, the meeting on Oct. 26 will see regulators consider COVAXIN as a candidate for an emergency-use listing (EUL).
By Chris MacDonald, InvestorPlace Contributor
The outcome of the meeting will decide put positions on OCGN.
BILL GATES WANTS US TO EAT 100% SYNTHETIC BEEF.
26 October 2021
Bill Gates suggests synthetic beef like Beyond Meat is a key part of climate action.
Lab-grown meat still has extremely high costs, but taste-wise, it has passed muster.
Gates pushes meat alternatives because of meat’s high cost in global emissions.
By Caroline Delbert, Yahoo Singapore
I think eventually plant based food will play a key part in people's diet. Will Tattooed Chef become a food giant?
WHY CORTEXYME SHARES ARE PLUNGING 70% AFTER HOURS?
October 27, 2021
The company stated co-primary endpoints were not met for ADAS-Cog11 and ADCS-ADL in the overall population. Subgroups saw a 50% slowing level for infection for ADAS-Cog11.
The company’s orally administered small-molecule targets “gingipain proteases from the bacterium Porphyromonas gingivalis."
A statistical significance was not hit by the company in the 643 person study for patients with mild to moderate Alzheimer’s disease.
What’s Next: The company said it report additional GAIN trial data at CTAD (Clinical Trials on Alzheimer’s Disease) 2021 on Nov. 11.
By Chris Katje, Benzinga
For me will have to wait for the price to settle down. My option trade expires in Nov 19. All is not lost for now.
OCUGEN REVERSES COURSE FROM MONDAY'S MASSIVE SURGE AS COVID-19 VACCINE PARTNER FACES WHO SETBACK
October 27, 2021
The World Health Organization’s (WHO) technical advisory group on Tuesday sought “additional clarifications” from Bharat Biotech to conduct a final “risk-benefit assessment” before the vaccine’s approval for emergency use listing, the Times of India newspaper reported.
The WHO also reportedly said its technical advisory group expects to receive these clarifications from Bharat Biotech by the end of this week and meet on Nov. 3 for a final assessment.
by Madhukumar Warrier, Benzinga
Price should be hover between 8+ to 9+ until WHO announcement next week.
ALPHABET BEATS SALES ESTIMATES, POSTS RECORD PROFIT ON GOOGLE AD SURGE
October 27, 2021
Google owner Alphabet Inc on Tuesday beat expectations for third-quarter revenue, a positive sign that its advertising business is overcoming new limits on tracking mobile users.
Through its search engine, YouTube video service and partnerships across the Web, Google sells more internet ads than any other company. Demand for its services surged in the past year as the pandemic forced people to spend more time online, and their new habits have persisted.
Google advertising revenue rose 41% to $53.1 billion during the third quarter. Alphabet's overall sales jumped to $65.1 billion, above the average estimate of $63.336 billion among analysts tracked by Refinitiv.
Quarterly profit was $18.936 billion or $27.99 per share, beating expectations of $24.08 per share and marking a third-straight quarter of record profit.
By Paresh Dave and Nivedita Balu | Reuters
Good enough results for my Goog bull put spread this week. Probably stock price is already priced in, thus a slight dip in after hours.
WHY ROBINHOOD STOCK CRASHED TODAY?
October 28, 2021
Shares of Robinhood (NASDAQ:HOOD) sank 10.4% on Wednesday after the online brokerage's third-quarter financial results disappointed shareholders amid a shortfall in cryptocurrency trading volumes.
Robinhood's revenue rose 35% year over year to $365 million. That was well below Wall Street's expectations for revenue of $431.5 million. It also represented a sharp decline from the $565 million in revenue Robinhood generated in the second quarter.
Worse still, monthly active users declined 11% sequentially, to 18.9 million. Robinhood expects the muted trading activity to persist into year-end.
By Joe Tenebruso (TMFGuardian)
Started a Leap call option of robinhood yesterday. Will sell covered call in the mean time while waiting for it to go higher.
WHY TRITERRAS STOCK ROSE A HUGE 58%?
October 29, 2021
An independent audit of the company had been underway since January. Triterras' board finally reported the results of that review, saying it revealed that there was nothing funny going on.
According to the company, "...the Audit Committee has concluded that the allegations contained in the short report lack either factual support or material basis. Accordingly, the Audit Committee has concluded that those allegations do not require additional action by the Company."
The market took that as an all-clear, and -- with a material overhang on the stock apparently resolved -- investors jumped on the shares.
By Reuben Gregg Brewer , The Motley Fool.
Will be looking to sell put if price pull back, and if the premium is good.
GREENIDGE GENERATION STOCK CLIMBS AFTER COUNTY SUPPORTS AIR PERMIT RENEWAL
October 30, 2021
Crypto miner Greenidge Generation Holdings (NASDAQ:GREE) stock jumps 21% in midafternoon trading, possibly due to a county in New York putting its support behind the state renewing the company's air permit.
The show of support also comes as others in the state oppose Greenidge's (GREE) bitcoin mining operation and asked Governor Kathy Hochul to deny the company's air permits, according to WENY News.
Bitcoin (BTC-USD) rising to $62.5K may also be helping the stock.
The stock, reaching an intra-day high of $28.57, is still far below its $57 opening price on Sept. 15, the first day it traded as GREE after it merged with Support.com, which until then had traded under the SPRT ticker.
Last week, Greenidge (GREE) announced plans to expand beyond its New York state site.
By: Liz Kiesche, Seeking Alpha
Still very far from my entry price. Did a sell call at strike price 45 this week. The best for me is to repair to 55. Will see movement for next week before deciding.
